Monday, September 30, 2019

Ranitidine controversy: Which Indian pharma companies stand to lose?

Ranitidine controversy: Which Indian pharma companies stand to lose? NULL

from Moneycontrol Business News https://ift.tt/2nRJ8ks

No comments:

Post a Comment

FIIs ease bearish bets post-Budget, but charts warn of range-bound Nifty: Anand James

Foreign investors are reducing their negative bets on the market after the Budget. However, the market's overall sentiment remains delic...